The FDA’s Action Plan for AI-ML-Based Software As A Medical Device

by | Mar 1, 2021 | Uncategorized

In this webinar hosted from EMMA International’s Software Engineer, Govind Yatnalkar, he focuses on the recently released FDA’s action plan for regulating AI/ML-based software as a medical device (SaMD). He then dives into the five major action items provided in the action plan along with examples that define the actual regulation strategies for AI/ML-based SaMDs.

Get the Action Plan for AI-ML-based Software As A Medical Device Webinar

Fill out the form below, and the webinar will get sent directly to your inbox.

Govind Yatnalkar

Govind Yatnalkar

More Resources

Advances in Oncology

Advances in Oncology

AstraZeneca and Daiichi Sankyo are advancing their oncology collaboration with promising data for their ...

Ready to learn more about working with us?

Pin It on Pinterest

Share This